project id: TCGA-ESCA; case submitter id: TCGA-VR-A8EX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.97; rna integrity number: 7.7; age at index: 63; days to birth: -23226; days to death: 855; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1946; year of death: 2011; age at diagnosis: 23226; ajcc clinical m: M1a; ajcc clinical n: N1; ajcc clinical stage: Stage IVA; ajcc clinical t: T1; ajcc pathologic m: M1a; ajcc pathologic n: N1; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: No; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 1480; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-VR-A8EX-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;